-0.00207125103562555 -0.00207125103562555 0.00124275062137536 0.00248550124275072 0.000828500414250189 0 -0.00704225352112668 -0.00662800331400166
Sign Up Today X
Thanks for submitting the form.
Stockreport

Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]

Evolus, Inc. (EOLS)  More Company Research Source: Forbes
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
Evolus, the manufacturer behind neuromodulator Jeuveau, soft-launched its new membership, Club Evolus, in early November—a new option for budget-conscious consumers who are looking to keep up their neuromodulator treatment schedule. Club Evolus charges users $49 per month for a treatment consisting of 20 units of Jeuveau, available every 90 days. Depending on the provider, Jeuveau often costs around $13 per unit, meaning members can see about $113 in savings per treatment. The program has approximately 100 practices enrolled for 2024, with plans to expand in 2025. The introduction of Club Evolus arrives at an inflection point for the injectable aesthetics market. According to The American Society of Plastic Surgeons, there was a 9% increase in neuromodulator use between 2022 and 2023, the latest statistics available. That includes Jeuveau, Daxxify, Xeomin, and Botox, which temporarily freeze or relax muscles in areas like the forehead and eyes where wrinkles develop. However, the [Read more]
IMPACT SNAPSHOT EVENT TIME: EOLS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
EOLS alerts
from News Quantified
EOLS
NEWS
EOLS
Earnings
EOLS
Analyst Actions
EOLS
SEC Filings
Stockreport

Botox Competitor Jeuveau Launches A $49-A-Month Membership [Forbes]

Evolus, Inc.  (EOLS) 
More Company Research Source: Forbes
Last evolus, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
Evolus, the manufacturer behind neuromodulator Jeuveau, soft-launched its new membership, Club Evolus, in early November—a new option for budget-conscious consumers who are looking to keep up their neuromodulator treatment schedule. Club Evolus charges users $49 per month for a treatment consisting of 20 units of Jeuveau, available every 90 days. Depending on the provider, Jeuveau often costs around $13 per unit, meaning members can see about $113 in savings per treatment. The program has approximately 100 practices enrolled for 2024, with plans to expand in 2025. The introduction of Club Evolus arrives at an inflection point for the injectable aesthetics market. According to The American Society of Plastic Surgeons, there was a 9% increase in neuromodulator use between 2022 and 2023, the latest statistics available. That includes Jeuveau, Daxxify, Xeomin, and Botox, which temporarily freeze or relax muscles in areas like the forehead and eyes where wrinkles develop. However, the [Read more]
IMPACT SNAPSHOT
EVENT TIME:
EOLS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS